Invega Hafyera

Invega Hafyera Indications/Uses

paliperidone

Manufacturer:

Janssen

Distributor:

DCH Auriga - Healthcare
/
Four Star
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Indications/Uses
INVEGA HAFYERA, an every-six-month injection, is indicated for the treatment of schizophrenia in adults after they have been adequately treated with: A once-a-month paliperidone palmitate prolonged-release suspension for injection (e.g., INVEGA SUSTENNA) for at least four months, or; An every-three-month paliperidone palmitate prolonged-release suspension for injection (e.g., INVEGA TRINZA) for at least one three-month cycle.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in